42 results
424B3
PRE
Prenetics Global Limited
21 Jul 23
Prospectus supplement
6:16am
in 2014 with a mission to revolutionize healthcare by integrating consumer health and genetics, and breakthrough technology for early cancer detection … .
BUSINESS
Our Mission
Our mission is to revolutionize healthcare by integrating consumer health and genetics, and breaking through technology for early
POS AM
EX-10.24
PRE
Prenetics Global Limited
6 Jul 23
Prospectus update (post-effective amendment)
9:00am
undertaking any special work or services for, or undertaking any special mission on behalf of, the Company other than his ordinary routine work
POS AM
PRE
Prenetics Global Limited
6 Jul 23
Prospectus update (post-effective amendment)
9:00am
prevention, early detection and treatment of cancer. Our business was founded in 2014 with a mission to revolutionize healthcare by integrating consumer … conditions, and other factors that our board of directors may deem relevant.
BUSINESS
Our Mission
Our mission is to revolutionize healthcare by integrating
6-K
EX-99.1
PRE
Prenetics Global Limited
26 Jun 23
Current report (foreign)
8:45am
governments that align with our vision – a commitment to save lives through the power of early cancer detection. Given the scale of our mission to combat … a substantial market opportunity, which Prenetics estimates at US$6 billion. Insighta’s focus underscores our mission of saving lives through early cancer
6-K
EX-99.1
PRE
Prenetics Global Limited
5 Jun 23
Prenetics Announces First Quarter 2023 Financial Results
7:18am
care through advanced genomic and molecular technologies. Our mission is to revolutionize healthcare by integrating consumer health and genetics
POS AM
b1mclg
31 May 23
Prospectus update (post-effective amendment)
8:25am
POS AM
vpl5l3p7 sfwtfe
1 May 23
Prospectus update (post-effective amendment)
5:19pm
6-K/A
EX-99.1
69c62gka
1 May 23
Prenetics Announces Fourth Quarter and Full Year 2022 Financial Results
4:03pm
6-K
EX-99.1
9iz0kq eso
16 Dec 22
Prenetics Acquires ACT Genomics, Creating a Leader in Comprehensive Cancer Genetics and Precision Oncology
8:06am
POS AM
imgakelxot
14 Dec 22
Prospectus update (post-effective amendment)
8:04am
6-K
EX-99.1
gm7 k9ckuzukjfarw
30 Nov 22
Prenetics Announces US$20 Million Stock Repurchase Program and Inclusion into the MSCI Global Micro Cap Index
6:15am
6-K
EX-99.1
rjcirmo3c509 95
10 Nov 22
Prenetics Announces Record Third Quarter 2022 Financial Results and Raises Full Year 2022 Revenue and EBITDA Guidance
4:04pm
6-K
EX-99.1
ib3x1a4ontq3dlqa3ji1
9 Sep 22
Prenetics Announces Second Quarter 2022 Financial Results and Raises Full Year Adjusted EBITDA Outlook
4:32pm
424B3
i45kznwp48uxwp2ll
1 Jul 22
Prospectus supplement
4:10pm
F-1/A
kcua4gdg62ad3
28 Jun 22
Registration statement (foreign) (amended)
4:02pm
F-1/A
ulpa mja5s2hqyw
21 Jun 22
Registration statement (foreign) (amended)
5:07pm
F-1/A
blt4ir188 ue0
10 Jun 22
Registration statement (foreign) (amended)
4:02pm
6-K
EX-99.1
ak99v w60u4i
6 Jun 22
Current report (foreign)
7:39am
F-1
pbiig40hbxnsttmuqc3p
27 May 22
Registration statement (foreign)
4:26pm